Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact Contact Barchart
Market:
Acumen Pharmaceuticals Inc (ABOS)
Acumen Pharmaceuticals Inc (ABOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
MarketBeat Week in Review – 7/17 - 7/21 MarketBeat - Sat Jul 22, 6:00AM CDT

Investor sentiment remains strong but upcoming tech earnings and an expected interest rate hike may provide more clarity on the short-term outlook for stocks

U : 30.36 (+3.37%)
MSFT : 378.85 (-1.01%)
META : 332.20 (-2.00%)
GOOGL : 134.99 (-1.61%)
NVDA : 481.40 (+0.67%)
RXRX : 7.05 (+0.43%)
OPK : 1.5300 (-1.92%)
PFE : 30.08 (+1.31%)
TSLA : 244.14 (-1.05%)
AAPL : 189.37 (-0.54%)
GP : 2.74 (+4.98%)
JNJ : 152.11 (+0.32%)
Author
Acumen Soars on Alzheimer's Study...Street Sees It Doubling MarketBeat - Wed Jul 19, 8:59AM CDT

Will the $11.00 level be a double-top ceiling…or can Acumen Pharmaceuticals build momentum and climb towards its $25.00 IPO price?

ABOS : 2.25 (-0.44%)
LLY : 591.86 (+0.04%)
BIIB : 232.06 (+2.04%)
Why Shares of Acumen Pharmaceuticals Are Down Tuesday Motley Fool - Tue Jul 18, 10:32AM CDT

The company announced a $100 million stock sale.

ABOS : 2.25 (-0.44%)
Wall Street - shutterstock_1321462394
Stock Index Futures Muted Ahead of Key U.S. Retail Sales Data, U.S. Bank Earnings on Tap Barchart - Tue Jul 18, 4:28AM CDT

September S&P 500 futures (ESU23) are down -0.03%, and September Nasdaq 100 E-Mini futures (NQU23) are down -0.10% this morning as market participants braced for the next round of quarterly reports while...

ESU23 : 4,491.72s (-0.32%)
NQU23 : 15,435.20s (-0.28%)
TSLA : 244.14 (-1.05%)
AAPL : 189.37 (-0.54%)
ATVI : 94.42 (-0.05%)
MSFT : 378.85 (-1.01%)
F : 10.59 (+2.12%)
T : 16.30 (+0.74%)
BAC : 30.31 (+2.64%)
MS : 78.55 (+2.17%)
PLD : 113.04 (+0.83%)
LMT : 445.01 (-0.73%)
Is Novo Nordisk (NVO) Stock Outpacing Its Medical Peers This Year? Zacks - Fri Jan 6, 8:40AM CST

Here is how Novo Nordisk (NVO) and Acumen Pharmaceuticals, Inc. (ABOS) have performed compared to their sector so far this year.

NVO : 102.00 (+0.56%)
ABOS : 2.25 (-0.44%)
Acumen Pharmaceuticals, Inc. (ABOS) Q2 2022 Earnings Call Transcript Motley Fool - Mon Aug 15, 2022

ABOS earnings call for the period ending June 30, 2022.

ABOS : 2.25 (-0.44%)
Acumen Pharmaceuticals to Report Second Quarter 2022 Financial Results on August 15, 2022 Globe Newswire - Mon Aug 8, 2022

CHARLOTTESVILLE, Va. and CARMEL, Ind., Aug. 08, 2022 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical stage biopharmaceutical...

ABOS : 2.25 (-0.44%)
Acumen presents poster describing method to standardize amyloid beta oligomer assays supporting therapeutic development for early Alzheimer’s disease Globe Newswire - Mon Aug 1, 2022

Model designed to fill need for soluble amyloid beta oligomer reference standards in bioanalytical assays...

ABOS : 2.25 (-0.44%)
Acumen Pharmaceuticals to Participate in Upcoming Investor and Scientific Conferences Globe Newswire - Tue Jul 26, 2022

CHARLOTTESVILLE, Va. and CARMEL, Ind., July 26, 2022 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical stage biopharmaceutical...

ABOS : 2.25 (-0.44%)
Acumen Pharmaceuticals, Inc. (ABOS) Q1 2022 Earnings Call Transcript Motley Fool - Mon May 16, 2022

ABOS earnings call for the period ending March 31, 2022.

ABOS : 2.25 (-0.44%)

Barchart Exclusives

1 Top Crypto Stock to Buy for Bitcoin Exposure Barchart - Wed Nov 29, 2:19PM CST
MicroStrategy is effectively a Bitcoin holding company, and its share price is tied to the performance of Bitcoin. Should you buy MSTR stock at the current valuation? Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot